ChemicalBook > CAS DataBase List > NSI-189

NSI-189

Product Name
NSI-189
CAS No.
1270138-40-3
Chemical Name
NSI-189
Synonyms
CS-1018;NSI-189;NIS-?189;NSI-189 base;NSI-189, >=98%;NSI189; NSI 189;NSI-189 free base;NSI-189 and its phosphate;(4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl];(4-BENZYLPIPERAZIN-1-YL)(2-(ISOPENTYLAMINO)PYRIDIN-3-YL)METHANONE
CBNumber
CB32672989
Molecular Formula
C22H30N4O
Formula Weight
366.5
MOL File
1270138-40-3.mol
More
Less

NSI-189 Property

Boiling point:
534.7±50.0 °C(Predicted)
Density 
1.134±0.06 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
Soluble in DMSO
pka
6.18±0.10(Predicted)
form 
A crystalline solid
color 
White to yellow
λmax
254 nm
InChI
InChI=1S/C22H30N4O/c1-18(2)10-12-24-21-20(9-6-11-23-21)22(27)26-15-13-25(14-16-26)17-19-7-4-3-5-8-19/h3-9,11,18H,10,12-17H2,1-2H3,(H,23,24)
InChIKey
DYTOQURYRYYNOR-UHFFFAOYSA-N
SMILES
C(C1=CC=CN=C1NCCC(C)C)(N1CCN(CC2=CC=CC=C2)CC1)=O
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H335May cause respiratory irritation

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
26166
Product name
NSI-189
Packaging
1mg
Price
$81
Updated
2024/03/01
Cayman Chemical
Product number
26166
Product name
NSI-189
Packaging
5mg
Price
$356
Updated
2024/03/01
TRC
Product number
N900600
Product name
NIS-​189
Packaging
50mg
Price
$60
Updated
2021/12/16
TRC
Product number
N900600
Product name
NIS-​189
Packaging
100mg
Price
$70
Updated
2021/12/16
AK Scientific
Product number
J10998
Product name
NIS-189
Packaging
5mg
Price
$57.2
Updated
2021/12/16
More
Less

NSI-189 Chemical Properties,Usage,Production

Description

NSI-189 is an investigational drug being developed by Neuralstem Inc., a biopharmaceutical company. NSI-189 is a small molecule in clinical development for major depressive disorder (MDD) and in preclinical development for Angelman syndrome, irradiation-induced cognitive impairment, Type 1 and Type 2 diabetes, and stroke. NSI-189 was studied in phase I and II clinical trials for the treatment of major depressive disorder. As of July 2017, NSI-189 has failed to meet effectiveness outcomes for depression in phase II trials.

Uses

NSI-189 is an experimental, potential antidepressant, for the treatment for major depressive disorder (MDD), as well as for cognitive impairment and neurodegeneration.

Side effects

NSI 189 is not approved by the FDA, and there is not enough scientific information available to verify its safety. To lessen any potential side effects, it is advisable to only take the lowest possible dose of the compound at first in order to judge how it will affect the body. The possible side effects of this compound include nausea, fatigue, heart palpitations, headache, increased anxiety, visual perception changes, loss of memory, dissociation, decreased appetite, increased heart rate, delirium, and a drop in blood sugar.
As there have been no long term studies for this compound, the long term effects and overall safety are unknown. For this reason, it is not suggested to take the compound if an individual is pregnant or breastfeeding. It is also not advisable to take the compound if an individual is taking a prescription medication for the treatment of depression, neuropathy, or if they have low blood sugar.

Clinical claims and research

NSI-189 completed a phase I clinical trial for MDD in 2011, where it was administered to 41 healthy volunteers.A phase Ib clinical trial for treating MDD in 24 patients started in 2012 and completed in July 2014, with results published in December 2015. In July 2017, it was announced that a phase II clinical trial with 220 patients failed to meet its primary effectiveness endpoint in MDD.Upon the announcement, Neuralstem stock plummeted by 61%.More detailed analysis of the trial results was released in December 2017 and January 2018. The compound has gone through phase I and II clinical trials for its antidepressant properties, but the phase II trial failed to meet effectiveness outcomes. It is currently still being studied as a possible treatment for other conditions.

Mode of action

NSI-189 is a compound that may increase the birth of new neurons (neurogenesis) in the brain area known as the hippocampus. It works by stimulating the growth of new brain cells and nerve cells through a process called neurogenesis. The neurogenesis appears to affect the hippocampus primarily, which is responsible for learning, memory, and emotion. Scientists believe the compound has the potential to treat various neurological and nerve conditions.

NSI-189 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

NSI-189 Suppliers

Weifu (Shanghai) Pharmaceutical Technology Co., LTD
Tel
021-57609736 13524092974;
Email
info@shanghaiweifu.cn
Country
China
ProdList
237
Advantage
58
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Fax
021-64823266
Email
chenyj@titansci.com
Country
China
ProdList
14103
Advantage
59
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
19173
Advantage
64
SHANGHAI HOHANCE CHEMICAL CO.,LTD
Tel
021-31115312 18217084087
Fax
86 021 31115317
Email
mary@hohance.com
Country
China
ProdList
143
Advantage
62
Wuhan Vanzpharm Inc.
Tel
027-84492310 13657243668
Fax
027-84492310
Email
wangting@vanzpharm.com
Country
China
ProdList
53
Advantage
58
Shanghai Topbiochem Technology Co., Ltd
Tel
+86-21-60341587
Fax
+86-21-61294319
Email
sales@topbiochem.com
Country
China
ProdList
6175
Advantage
58
UHN Shanghai Research & Development Co., Ltd.
Tel
021-58958002 18930822973
Fax
+86 (21) 5895-8628
Email
SALES@UHNSHANGHAI.COM
Country
China
ProdList
977
Advantage
58
China Nobel Chem Co., Limited
Tel
+86(0)21 60484900
Fax
+86(0)21 60484900
Country
China
ProdList
764
Advantage
50
Suzhou Pharmaceutical Technology co.,ltd
Tel
0510-88771160 18051901298
Fax
0510-8877116
Email
2013446823@qq.com
Country
China
ProdList
52
Advantage
61
CEG Chemical Science&Technology Co., Ltd.
Tel
Mobile:13665161512
Fax
+86-510-68873513
Country
China
ProdList
1785
Advantage
58
More
Less

View Lastest Price from NSI-189 manufacturers

Hebei Zhuanglai Chemical Trading Co.,Ltd
Product
NSI-189 1270138-40-3
Price
US $40.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
5000kg/week
Release date
2024-05-17
hebei hongtan Biotechnology Co., Ltd
Product
NSI-189 1270138-40-3
Price
US $20.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
2000kg
Release date
2024-03-20
Wuhan Nutra Biotechnology Co.,Ltd
Product
NSI-189 free base 1270138-40-3
Price
US $10.00-0.00/g
Min. Order
1g
Purity
98%+
Supply Ability
100kgs
Release date
2021-05-26

1270138-40-3, NSI-189Related Search:


  • NSI-189
  • (4-BENZYLPIPERAZIN-1-YL)-[2-(3-METHYLBUTYLAMINO)PYRIDIN-3-YL]METHANONE
  • (4-BENZYLPIPERAZIN-1-YL)(2-(ISOPENTYLAMINO)PYRIDIN-3-YL)METHANONE
  • [2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone
  • [2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone NSI189
  • NSI-189 [2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]methanone
  • NSI-189, >=98%
  • (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]
  • NSI-189 free base
  • (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl],NSI-189
  • CS-1018
  • NSI-189 base
  • NSI189; NSI 189
  • Methanone, [2-[(3-methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]-
  • NIS-?189
  • NSI-189 (4-benzylpiperazin-1-yl)-[2- (3-methylbutylamino)pyridin- 3-yl]methanone
  • NSI-189 and its phosphate
  • 1270138-40-3
  • 50922-68-1
  • Inhibitors
  • API